Chlorothiazide
Chlorothiazide Sodium for Injection, USP
Approved
Approval ID
de250776-461a-4d02-a82e-ffedca1a9cf4
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jun 2, 2023
Manufacturers
FDA
Fresenius Kabi USA, LLC
DUNS: 608775388
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
CHLOROTHIAZIDE SODIUM
PRODUCT DETAILS
NDC Product Code63323-658
Application NumberANDA090896
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateJune 2, 2023
Generic NameCHLOROTHIAZIDE SODIUM
INGREDIENTS (3)
MANNITOLInactive
Quantity: 250 mg in 18 mL
Code: 3OWL53L36A
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
CHLOROTHIAZIDE SODIUMActive
Quantity: 500 mg in 18 mL
Code: SN86FG7N2K
Classification: ACTIM